Triplet combination chemotherapy and targeted therapy regimens

ONCOLOGY

Volumn 15, Issue 3 SUPPL. 6, 2001, Pages 26-32

  Bunn Jr , Paul A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG COMBINATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; DRUG THERAPY, COMBINATION; HUMAN; LUNG NEOPLASMS;

EID: 0035294662     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bunn PA, Kelly K: New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 5:1087-1100, 1998.
2. Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311:899-909, 1995.
3. Cullen MH, Billingham LJ, Woodroffe CM, et al: Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life. J Clin Oncol 17(10):3188-3194, 1999.
4. Sandler AB, Nemunaitis J, Denham, et al: Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18(1): 122-130, 2000.
5. Bonomi P, KyungMann K, Fairclough D, et al: Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18(3):623-631, 2000.
6. Wozniak AJ, Crowley JJ, Balcerzak SP, et al: Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study. J Clin Oncol 16(7):2459-2465, 1998.
7. Kelly K, Crowley J, Bunn PA, et al: Randomized phase III trial of paclitaxel plus carboplatin (PC) versus vinorelbine plus cisplatin in untreated advanced non-small-cell lung cancer: A Southwest Oncology Group trial (abstract 1777). Proc Am Soc Clin Oncol 18:46 la, 1999.
8. Schiller JH, Harrington, D, Sandier A, et al: A randomized phase III trial of four chemotherapy regimens in advanced non-small-cell lung cancer (abstract 2). Proc Am Soc Clin Oncol 19: la, 2000.
9. Bergman AM, Ruiz CM, Harpern VW, et al: Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2:521-530, 1996.
10. LeChavalier T: Single agent activity of gemcitabine in advanced non-small-cell lung cancer. Semin Oncol 23(suppl):36-42, 1996.
11. Chadedbech P, Truchet I, Buchere L, et al: Up-regulation of cdc2 protein during paclitaxel induced apoptosis. Int J Cancer 87:779-786, 2000.
12. Ranson M, Davidson N, Nicolson M, et al: Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92(13): 1074-1080, 2000.